Cohort Primary Hyperparathyroidism
CoHPT
Prospective Cohort Primary Hyperparathyroidism
1 other identifier
observational
403
1 country
1
Brief Summary
CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2022
CompletedFirst Submitted
Initial submission to the registry
July 7, 2022
CompletedFirst Posted
Study publicly available on registry
July 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2027
ExpectedSeptember 8, 2025
August 1, 2025
5.9 years
July 7, 2022
August 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Occurrence of cardiovascular events, after parathyroidectomy for primary hyperparathyroidism
Cardiovascular events include myocardial infarction, cerebrovascular and peripheral arterial events
Between inclusion and 12 months after surgery
Change in LDL-cholesterol concentration after surgery
Plasma LDL-cholesterol (mg/dL) will be directly measured using enzymatic method
Between inclusion and 12 months after surgery
Change in HDL-cholesterol concentration after surgery
Plasma HDL-cholesterol (mg/dL) will be measured using enzymatic method
Between inclusion and 12 months after surgery
Change in plasma triglycerides concentration after surgery
Plasma triglycerides (mg/dL) will be measured using enzymatic method
Between inclusion and 12 months after surgery
Change in homeostasis model assessment HOMA-IR index after surgery
HOMA-IR is calculated using fasting plasma glucose and insulin level, with the following formula: (fasting plasma insulin (mIU/L) × fasting plasma glucose (mmol/L))/22.5
Between inclusion and 12 months after surgery
Change in homeostasis model assessment HOMA-B index after surgery
HOMA-B is calculated using fasting plasma glucose and insulin level, with the following formula: 20 × fasting plasma insulin (mIU/L)/\[fasting plasma glucose (mmol/L) - 3.5\]
Between inclusion and 12 months after surgery
Change in arterial stiffness after surgery
Arterial stiffness is reflected by the measurement of the pulse wave velocity using the PoPmeter® instrument
Between inclusion and 12 months after surgery
Secondary Outcomes (21)
Occurrence of cardiovascular events, after parathyroidectomy for primary hyperparathyroidism
Between inclusion and 60 months after surgery
Change in LDL-cholesterol concentration after surgery
Between inclusion and 60 months after surgery
Change in HDL-cholesterol concentration after surgery
Between inclusion and 60 months after surgery
Change in plasma triglycerides concentration after surgery
Between inclusion and 60 months after surgery
Change in homeostasis model assessment HOMA-IR index after surgery
Between inclusion and 60 months after surgery
- +16 more secondary outcomes
Eligibility Criteria
All consecutive patients consulting for sporadic primary hyperparathyroidism in Nantes University Hospital
You may qualify if:
- Age \> 18
You may not qualify if:
- Age \< 18
- Pregnancy / lactation
- Adults underguardianship
- Secondary/tertiary hyperparathyroidism
- Multiple endocrine neoplasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France
Related Publications (2)
Loison M, Wargny M, Caillard C, Guillot P, Le Bras M, Cariou B, Blanchard C, Mirallie E, Frey S. Radius Bone Mineral Density Measurement Is Essential During Initial PHPT Workup: Results of a Retrospective Study on 400 Patients. World J Surg. 2026 Jan 4. doi: 10.1002/wjs.70223. Online ahead of print.
PMID: 41486083DERIVEDFrey S, Perrot B, Caillard C, Le Bras M, Gerard M, Blanchard C, Cariou B, Wargny M, Mirallie E. Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort study. Int J Surg. 2023 Mar 1;109(3):364-373. doi: 10.1097/JS9.0000000000000282.
PMID: 36917123DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2022
First Posted
July 21, 2022
Study Start
March 31, 2016
Primary Completion
February 24, 2022
Study Completion (Estimated)
February 24, 2027
Last Updated
September 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share